Skip to main contentSkip to navigation
Sirius Investors

VICP Stock: Vicapsys Life Sciences, Inc. Stock Price, Analysis & Insights

Get live VICP stock price $1.46, comprehensive Vicapsys Life Sciences, Inc. stock analysis, charts, news, and expert forecast. Real-time VICP stock data and investment insights.

1.46
0.00%Today
VICPVicapsys Life Sciences, Inc. • Other OTC • Healthcare
Market Cap
47.26M
Volume
100
52W High
1.77
52W Low
0.15

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for...

Company Information

CEO
Federico Pier
Sector
Healthcare
Industry
Biotechnology
Employees
2

Contact Information

Address
1735 Buford Highway
Country
US

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: -4.13) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Vicapsys Life Sciences, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Vicapsys Life Sciences, Inc.
  • Investors should consider how Vicapsys Life Sciences, Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

47.26M

P/E Ratio (TTM)

-48.67

Beta

-4.13

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.